glp-1 from china approves first home-grown weight loss drug, rivaling Ozempic | Yanzhong Huang posted on the topic China approves Pfizer GLP-1 drug
Description
Only peer-reviewed, indexed publications were considered
Instead, binding of leptin to LepRb initiates a signaling cascade beginning with activation of the tyrosine kinase of the Jak kinase family (JAK2) [84, 85]
However, the drug regulatory authorities have also documented rare and occasional severe side effects associated with using GLP-1 agonists, especially GI disease
Statistical analysis All data were expressed as the mean SEM
: 30
More People Are Overdosing on Ozempic Alternatives, The New York Times, August 6, 2024.
